Study S001929

A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy and Safety of RO6807952 in Type 2 Diabetic Patients Inadequately Controlled With Metformin Alone

ClinicalTrials.gov record

Registration

Registration: NCT01516476
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: TERMINATED
Enrollment: 2
Start: 2011-11
Primary completion: 2012-01
Lead sponsor: Hoffmann-La Roche
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG:Placebo; DRUG:RO6807952; DRUG:liraglutide
Results posted: FALSE

Registered primary outcomes

Change in hemoglobin A1c (HA1c) [Baseline and 12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.